相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β
Hisham F. Bahmad et al.
PHARMACOLOGICAL REPORTS (2021)
Zerumbone Promotes Cytotoxicity in Human Malignant Glioblastoma Cells through Reactive Oxygen Species (ROS) Generation
Mohammad Jalili-Nik et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway
Mohammad Soukhtanloo et al.
PHARMACOLOGICAL REPORTS (2020)
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Ryan C. Gimple et al.
GENES & DEVELOPMENT (2019)
Estimation of the radiation-induced DNA double-strand breaks number by considering cell cycle and absorbed dose per cell nucleus
Ryosuke Mori et al.
JOURNAL OF RADIATION RESEARCH (2018)
Antagonistic role of GSK3 isoforms in glioma survival
Vidhi Vashishtha et al.
JOURNAL OF CANCER (2018)
Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
Hisham F. Bahmad et al.
FRONTIERS IN ONCOLOGY (2018)
Correlative Studies Unravelling the Possible Mechanism of Cell Death in Tideglusib-Treated Human Ovarian Teratocarcinoma-Derived PA-1 Cells
Theodore Lemuel Mathuram et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2017)
Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications
Tamara J. Abou-Antoun et al.
NEUROTHERAPEUTICS (2017)
Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases
Romina Mancinelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Multiscale cytometry and regulation of 3D cell cultures on a chip
Sebastien Sart et al.
NATURE COMMUNICATIONS (2017)
Glioblastoma targeted therapy: updated approaches from recent biological insights
M. Touat et al.
ANNALS OF ONCOLOGY (2017)
pATM and γH2AX are effective radiation biomarkers in assessing the radiosensitivity of 12C6+ in human tumor cells
Jin Zhao et al.
CANCER CELL INTERNATIONAL (2017)
Gsk-3β Controls Autophagy by Modulating LKB1-AMPK Pathway in Prostate Cancer Cells
Aijing Sun et al.
PROSTATE (2016)
Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0/G1 accumulation and ROS generation
Theodore Lemuel Mathuram et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2016)
Individual response to ionizing radiation
Nicolas Foray et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
Yang Yi et al.
FRONTIERS IN PHARMACOLOGY (2016)
Recent advances in targeted therapy for glioblastoma
Shivani Mittal et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Recent advances in targeted therapy for glioblastoma
Shivani Mittal et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
Tarek H. Mouhieddine et al.
FRONTIERS IN NEUROSCIENCE (2015)
A Phase II Trial of Tideglusib in Alzheimer's Disease
Simon Lovestone et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches
Frederic Dhermain
CHINESE JOURNAL OF CANCER (2014)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Juan Manuel Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Jia Luo
CANCER LETTERS (2009)
Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Katsuyoshi Miyashita et al.
CLINICAL CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Cancer stem cells in nervous system tumors
SK Singh et al.
ONCOGENE (2004)
Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy
KC Yao et al.
JOURNAL OF NEUROSURGERY (2003)
分享论文
